We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.
BLPH

Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

22 hedge funds and large institutions have $507K invested in Bellerophon Therapeutics, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 23 → 22 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

39% less capital invested

Capital invested by funds: $825K → $507K (-$318K)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
8
Closed
5
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$58.1K
2
Citadel Advisors
Citadel Advisors
Florida
+$21K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.54K
4
Two Sigma Investments
Two Sigma Investments
New York
+$4.99K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.25K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$18K
2
Osaic Holdings
Osaic Holdings
Arizona
-$14.8K
3
Wells Fargo
Wells Fargo
California
-$9.86K
4
Renaissance Technologies
Renaissance Technologies
New York
-$8.77K
5
TSS
Two Sigma Securities
New York
-$7.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
FGAM
26
Financial Gravity Asset Management
Texas
– -$18 -1 Closed
1
2

BLPH Hedge Fund Activity: Q3 2023 in Review

22 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q3 2023, worth a combined $507K — down 39% from $825K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BLPH and 4 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 3 added.

The largest buyer was Acadian Asset Management, adding an estimated $58.1K. The largest seller was Virtu Financial, exiting entirely with an estimated $18K sold.

  • 22 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q3 2023, down from 23 in Q2 2023.
  • Funds reported $507K of Bellerophon Therapeutics, Inc. stock for Q3 2023, down 39% quarter-over-quarter.
  • 4 funds opened new Bellerophon Therapeutics, Inc. positions in Q3 2023 and 5 closed out, a net change of -1 holder.
  • The largest Bellerophon Therapeutics, Inc. buyer in Q3 2023 was Acadian Asset Management, an estimated $58.1K added.
  • The largest Bellerophon Therapeutics, Inc. seller in Q3 2023 was Virtu Financial, an estimated $18K sold.

Based on aggregated 13F filings for Q3 2023.